Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
The same testing technique would also be used for monitoring in green zones districts which have reported no cases till now or in the last 21 days, the Union health ministry said while issuing 'Guidelines for RT-PCR based pooled sampling for migrants/returnees from abroad/green zones'.
'In spite of all the sermonising from the political class, when they come in public, the ministers don't follow their own rules.' 'They don't mask.' 'If you look at the West Bengal election campaigning, if you look at the Assam election campaigning or if you look at Kerala election campaigning, they are not setting an example.'
'The Indian Academy of Sciences, strongly believes that any hasty solution that may compromise rigorous scientific processes and standards will likely have long-term adverse impacts of unforeseen magnitude on citizens of India'
Researchers said outbreaks of such an illness have the potential to wreak economic havoc in many countries across the globe that rely on the pork industry.
The researchers said D614G has a small but effective change in the 'spike' protein that protrudes from the surface of the virus, which it uses to enter and infect human cells.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.
The findings, published in the journal Nature Human Behaviour, also show that, in countries that have not yet reached the peak of active cases, lockdowns must remain in place for at least 60 days and deconfinement must be gradual in order to decrease the risk of second waves.
Prior to the beginning of the nationwide vaccination drive against Covid-19 in India on January 16, the Pune-based Serum Institute of India has issued a factsheet to answer frequently asked questions that vaccine beneficiaries might have.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
'Vaccination is the only safe way to get immunity.'
The expose, which was in Chinese, said that the Chinese Communist Party was covering up the COVID-19 crisis and there was a human-to-human transmission of the virus.
A PTI tally of figures announced by states and UTs, as of 9.30 pm, showed the total number of confirmed cases having risen to close to 2.1 lakh and the death toll to approximately 6,000, showing an increase of nearly 9,000 cases since Tuesday evening and at least 273 more fatalities in this time period.
A number of countries like Canada, Turkey, Belgium, Italy and Israel have banned flights from the UK as the British government warned that the potent new strain of the virus was "out of control" and imposed a stringent new stay-at-home lockdown from Sunday.
Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.
'One thing we have learnt is that a pandemic can be arrested at any stage.' 'Not suddenly, of course, but slowly with steady unwavering focus.'
The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.
According to the research, published in the journal Frontiers in Pediatrics, gastrointestinal symptoms first suffered by some children hints at potential infection with SARS-CoV-2 through the digestive tract.
IMD has said the temperature in April-June across most parts in India is expected to be 0.5-1 degrees Celsius warmer than normal. However, doctors and scientists say they haven't found any direct correlation between the speed of COVID-19 spread and warm weather.
The agencies said that both pets had mild respiratory illness and are expected to make a full recovery. COVID19 infections have been reported in very few animals worldwide and mostly in those that had close contact with a person with COVID-19.
The researchers said the growth rate of COVID-19 is weakly linked to the outdoor weather, adding that the chances of the survival of the virus "increases roughly by five times under a humid condition as compared to a dry condition."
'But to see the effects of that, it will take a week or two more.'
Director of the National Centre for Disease Control (NCDC) Dr Sujeet Kumar Singh said the remaining 77 per cent are still vulnerable to the viral disease and containment measures need to continue with the same rigour.
The government said the use of such masks will help in protecting the community at large
It's a great friend to expecting mothers and their babies, explains Ranjana Sharma.
After the legendary success of RD350 and RX100, Yamaha Motors India had lost ground to rivals. And then the R15 happened!
However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
The researchers found that after being exposed to high levels of the novel coronavirus, none of the six monkeys that were given the vaccine developed viral pneumonia. Also, there was no sign that the vaccine had made the animals more vulnerable.
Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
The disease could go down several paths. One possibility, the least likely, is that it will just disappear. The most likely is that it will have seasonal impact, says Devangshu Datta.
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.
The apex health research body on Tuesday validated the 1,000th testing laboratory, ramping up the capacity for detection of COVID-19 in the country. Currently, three lakh samples can be tested per day, an official said.
FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.
Based on the observations, scientists said that additional care may be required for older men or those with underlying conditions. Yang and his team analysed several patient datasets to see if there were differences in how men and women respond to COVID-19.
'As people have moved from cities to small towns and villages, they have carried the infection into new territories.' 'Poor healthcare infrastructure in these places should be a big worry in the days to come.'
Also in action on the first day at Roland Garros is men's second seed Alexander Zverev who meets Ricardas Berankis of Lithuania on Court Suzanne-Lenglen.
'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.' 'Most of those people, who got infected this year, will be next year back to level zero -- once again susceptible.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances